TP53 and B-cell chronic lymphocytic leukemia: Levels of Ser15 phosphorylated p53 and p53 (Figure 1B), γH2AX baseline/formation (Figure 1C) and sensitivity to fludarabine (Figure 1D) appeared unaffected in treatment-naïve SF3B1-mutated CLL cases.